KWILP
JAZZ icon

Kiwi Wealth Investments Limited Partnership’s Jazz Pharmaceuticals JAZZ Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,717
Closed -$1.95M – 187
2018
Q4 		$1.95M Buy
+15,717
New +$2.33M 0.2% 119

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's JAZZ Position: Q1 2019 in Review

Kiwi Wealth Investments Limited Partnership sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2019, closing a stake of 15,717 shares — an estimated $1.95M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in JAZZ in Q4 2018 and held it in 1 quarter. The position peaked at $1.95M in Q4 2018. 427 funds tracked by Wall St. Rank hold JAZZ as of Q1 2019.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Jazz Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 15,717 Jazz Pharmaceuticals shares in Q1 2019, an estimated $1.95M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Jazz Pharmaceuticals in Q4 2018 and held it in 1 quarter.
  • Kiwi Wealth Investments Limited Partnership's Jazz Pharmaceuticals position peaked at $1.95M in Q4 2018.
  • 427 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2019.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q1 2019, filed 16 May 2019.